Literature DB >> 7610228

Epidemiologic characteristics of an outbreak of serogroup C meningococcal disease and the public health response.

P Houck1, M Patnode, R Atwood, K Powell.   

Abstract

An outbreak of serogroup C meningococcal disease occurred in six counties in the State of Washington from January 1989 through mid-1991. This report describes epidemiologic data collected from hospitals and health departments, the results of multilocus enzyme electrophoresis of isolates, and the vaccination of high-risk populations in one county. A total of 45 confirmed or probable cases (10 per 100,000 population) occurred. Infants younger than age 1, Hispanics and American Indians, and low-income populations had high attack rates. Nine (20 percent) patients died. The predominant enzyme type, ET-22, had not been detected previously in Washington. More than 22,000 persons were vaccinated in one of the counties. Major challenges to health care personnel included deciding when and where to employ vaccination, obtaining sufficient vaccine, and responding to public anxiety.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7610228      PMCID: PMC1382131     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  12 in total

1.  Mass voluntary immunization campaigns for meningococcal disease in Canada: media hysteria.

Authors:  S E Hume
Journal:  JAMA       Date:  1992-04-01       Impact factor: 56.272

2.  An outbreak of meningococcal disease in Ottawa-Carleton. December 1991-February 1992.

Authors:  I Gemmill
Journal:  Can J Public Health       Date:  1992 Mar-Apr

3.  Meningococcal disease and public health: welcome to the '90s.

Authors:  S Corber
Journal:  Can J Public Health       Date:  1992 Mar-Apr

4.  Invasive meningococcal disease, British Columbia. December 1991-March 1992.

Authors:  J D Farley; W Osei
Journal:  Can J Public Health       Date:  1992 Mar-Apr

5.  Group A meningococcal disease in the U.S. Pacific Northwest: epidemiology, clinical features, and effect of a vaccination control program.

Authors:  G W Counts; D F Gregory; J G Spearman; B A Lee; G A Filice; K K Holmes; J M Griffiss
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

6.  Prevention of meningococcal disease by group C polysaccharide vaccine.

Authors:  M S Artenstein; R Gold; J G Zimmerly; F A Wyle; H Schneider; C Harkins
Journal:  N Engl J Med       Date:  1970-02-19       Impact factor: 91.245

7.  Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children.

Authors:  R Gold; M L Lepow; I Goldschneider; T F Draper; E C Gotshlich
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

8.  Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations.

Authors:  W F Bibb; B Schwartz; B G Gellin; B D Plikaytis; R E Weaver
Journal:  Int J Food Microbiol       Date:  1989-06       Impact factor: 5.277

9.  Meningococcal disease in the United States--1986. Meningococcal Disease Study Group.

Authors:  R W Pinner; B G Gellin; W F Bibb; C N Baker; R Weaver; S B Hunter; S H Waterman; L F Mocca; C E Frasch; C V Broome
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

10.  Serogroup C meningococcal outbreaks in the United States. An emerging threat.

Authors:  L A Jackson; A Schuchat; M W Reeves; J D Wenger
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

View more
  4 in total

1.  Space-time cluster analysis of invasive meningococcal disease.

Authors:  Christian J P A Hoebe; Hester de Melker; Lodewijk Spanjaard; Jacob Dankert; Nico Nagelkerke
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

2.  Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.

Authors:  Femke van Kessel; Caroline van den Ende; Anouk M Oordt-Speets; Moe H Kyaw
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

3.  Mass vaccination campaign following community outbreak of meningococcal disease.

Authors:  Gérard Krause; Carina Blackmore; Steven Wiersma; Cheryll Lesneski; Laurey Gauch; Richard S Hopkins
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

Review 4.  The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review.

Authors:  Andrea Anonychuk; Gloria Woo; Andrew Vyse; Nadia Demarteau; Andrea C Tricco
Journal:  Pharmacoeconomics       Date:  2013-07       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.